Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples